Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 2Head & Neck 1

Conditions

Head and Neck Neoplasms 8Neoplasms 4Carcinoma, Squamous Cell 4Squamous Cell Carcinoma of Head and Neck 3Carcinoma 2Skin Neoplasms 1Recurrence 1Neoplasm Metastasis 1Laryngeal Diseases 1Breast Neoplasms 1

Interventions

pembrolizumab 8Radiotherapy 2Nivolumab 2Drug Therapy 2Biopsy 2pertuzumab 1liposomal doxorubicin 1cemiplimab 1cc-486 1brodalumab 1atezolizumab 1Trastuzumab 1Therapeutics 1Surveys and Questionnaires 1Semaxinib 1SUB1 protein, human 1Radiosurgery 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1Oxaliplatin 1Observation 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Lighting 1Isotretinoin 1Interleukin-2 1Interferon-alpha 1Injections 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Skin Neoplasms × Bleomycin × Head & Neck × Clear all
NCT00993512 2019-04-29

Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer

PCI Biotech AS

Phase 1 Completed
19 enrolled
DermatologicHead & Neck

Head and Neck Neoplasms, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡